Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IDEAYA Biosciences (IDYA) Income from Continuing Operations (2019 - 2025)

IDEAYA Biosciences' Income from Continuing Operations history spans 7 years, with the latest figure at 94570000.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations rose 34.39% year-over-year to 94570000.0; the TTM value through Dec 2025 reached 159313000.0, up 51.28%, while the annual FY2025 figure was 159313000.0, 51.28% up from the prior year.
  • Income from Continuing Operations for Q4 2025 was 94570000.0 at IDEAYA Biosciences, down from 108452000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 108452000.0 in Q3 2025 and bottomed at 144138000.0 in Q4 2024.
  • The 5-year median for Income from Continuing Operations is 29576000.0 (2022), against an average of 36674450.0.
  • The largest annual shift saw Income from Continuing Operations tumbled 5179.7% in 2023 before it soared 262.13% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 18369000.0 in 2021, then plummeted by 43.95% to 26443000.0 in 2022, then crashed by 58.52% to 41917000.0 in 2023, then tumbled by 243.87% to 144138000.0 in 2024, then skyrocketed by 34.39% to 94570000.0 in 2025.
  • Per Business Quant, the three most recent readings for IDYA's Income from Continuing Operations are 94570000.0 (Q4 2025), 108452000.0 (Q3 2025), and 88806000.0 (Q2 2025).